Monday, June 16, 2025
  • Home
  • About us
  • Privacy policy
  • Advertise with us
  • Contact us
Fii News Logo
No Result
View All Result
  • Tenders
  • Projects
  • Markets
  • Manufacturing
  • Investment
  • Technology
  • Exports
Newsletter
  • Tenders
  • Projects
  • Markets
  • Manufacturing
  • Investment
  • Technology
  • Exports
Fiinews
No Result
View All Result
Home Projects

Medivir forms partnership with GVK BIO

Fiinews by Fiinews
June 18, 2015
in Projects, Technology
Reading Time: 2 mins read
A A
0
0
SHARES
10
VIEWS
LinkedinShare on Twitter

0:00

Medivir AB has formed a partnership with GVK Biosciences Private Ltd. (GVK BIO) of Hyderabad in India, designed to deliver enhanced efficiency and quality within its portfolio of research projects while over time reducing overall research costs and enhancing future cost flexibility.
It is reorganization within its Discovery Research department, increasing its focus within the core areas of oncology and infectious diseases.
To ensure that its operations are run as efficiently as possible, Medivir has conducted a review of its Discovery Research operations. While committed to maintaining the current size of its discovery portfolio to deliver a constant flow of candidate drugs into its development pipeline, it has identified the opportunity to improve quality and efficiency through partnership with GVK BIO.
The partnership will consolidate and strengthen all current out-sourced synthetic chemistry in a single facility at GVK BIO’s Integrated Discovery Research Campus, where an addition of approximately 20 scientific staff will further accelerate the synthesis and testing of compounds.
The company has also decided to exit the neuropathic pain area, following adverse findings in non-clinical safety studies of MIV-247, its cathepsin S inhibitor being developed for neuropathic pain. Development of this program has been terminated and future drug discovery efforts will be focused in the core areas of oncology and infectious diseases.
As a result of the changes described above, around ten scientific staff at Medivir facilities in the UK and Sweden will be made redundant.


“We continue to assess all aspects of the productivity and cost-effectiveness of our businesses in order to drive innovation and maximize share-holder value” said Niklas Prager, Medivir CEO. “This reorganization and resource optimization will improve efficiency and enhance our ability to deliver well-differentiated candidate drugs into our development pipeline while over time reducing overall research costs and improving cost flexibility, and we look forward to a productive partnership with our colleagues at GVK BIO”.
“We are excited about GVK BIO’s partnership with Medivir. Medivir chose GVK BIO over several other CROs on the basis of its scientific strength and its ability to perform Integrated Research with Chemistry and Biology. We look forward to delivering significant value to Medivir shareholders and to a productive partnership” said Manni Kantipudi, CEO, GVK BIO
Medivir is required under the Securities Markets Act to make the information in this press release public. The information was submitted for publication at 08.30 CET on 16 June 2015.
The Nasdaq Stockholm Mid Cap List Medivir is a research based pharmaceutical company with a research focus on infectious diseases and oncology.

fii-news.com

ShareTweetShare

Related Posts

Dnv Grse
Projects

Project: DNV-India deepen maritime cooperation

by Fiinews
June 16, 2025
0
13

India’s maritime sector undergoes transformation Minister of Ports, Shipping and Waterways Sarbananda Sonowal has discussed deepening of co-operation between DNV...

PIB
Projects

Project: Joshi underlines Wind Energy strategy

by Fiinews
June 16, 2025
0
14

14 companies producing 33 wind energy models, says Minister Wind Energy is at the centre of India’s strategy for the...

Infobellit

Tech: Infobell-AMD expand AI collaboration

June 15, 2025
13
Mont Vert

Project: Mont Vert to build Kazakh Hospital

June 16, 2025
14
CMA CGM

Project: CMA CGM in discussions with Shipping entities

June 16, 2025
12
PIB

Project: Minister reviews GHAVP plant

June 16, 2025
13
SBI YONO

POPULAR NEWS

  • Cristina Dnv

    Projects: Indian yards set to build green ships, says DNV expert

    0 shares
    Share 0 Tweet 0
  • Market: Indian-origin UGF scales heritage consumer brands globally

    0 shares
    Share 0 Tweet 0
  • Technologies: Royal Diamond sponsors aerspace Industries’ drones in UAE

    0 shares
    Share 0 Tweet 0
  • Investments: Foreign investors see India as long-term destination for fund placings

    0 shares
    Share 0 Tweet 0
  • Markets: Blue Dart maintains positive outlook on India

    0 shares
    Share 0 Tweet 0

Fiinews.com features through news articles on business opportunities in the Indian market for the benefits of foreigners. It is also a platform for international businesses to showcase through elaborate articles on their products & services to the Indian consumers and corporations exploiting industrialisation of the country.

7Clicks Media is a Singapore based Media & PR company offering over 100,000
impressions via our targeted communication strategy.

It is led by editor-in-chief Gurdip Singh who has worked over 45 years reporting on
Asian businesses.

Recent News

  • Market: KBC expands into renewable sector
  • Project: DNV-India deepen maritime cooperation
  • Project: Joshi underlines Wind Energy strategy
  • Invest: PM welcomed Cyprus FDI in Indian economy
  • Tech: Infobell-AMD expand AI collaboration

Pages

  • About US
  • ADVERTISE ON FIINEWS.COM
  • CONTACT US
  • EVENTS
  • FII-NEWS.COM PDF ARCHIVE
  • Home
  • News
  • PRIVACY POLICY

Subscribe to Newsletter

  • About
  • Advertise
  • Careers
  • Contact us

© 2024 FIINEWS - Design and developed by 7clicksmedia.

No Result
View All Result
  • Tenders
  • Projects
  • Markets
  • Manufacturing
  • Investment
  • Technology
  • Exports

© 2024 FIINEWS - Design and developed by 7clicksmedia.